Bnp Paribas Asset Management Holding S.A. Vertex Pharmaceuticals Inc Transaction History

Bnp Paribas Asset Management Holding S.A.

$37.6 Billion
Q1 2024

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 486,875 shares of VRTX stock, worth $228 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

486,875

Previous 601,514 19.06%

Holding current value

$228 Million

Previous $245 Million 16.85%

% of portfolio

0.54%

Previous 0.68%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$407.69 - $446.08 $46.7 Million - $51.1 Million	-114,639 Reduced 19.06%	486,875 $204 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $30.4 Million - $36.4 Million	-88,634 Reduced 12.84%	601,514 $245 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $18 Million - $19.3 Million	53,366 Added 8.38%	690,148 $240 Million
Q2 2023 Aug 08, 2023	SELL	$314.42 - $351.91 $41.8 Million - $46.7 Million	-132,845 Reduced 17.26%	636,782 $224 Million
Q1 2023 May 08, 2023	BUY	$283.23 - $323.1 $27.4 Million - $31.3 Million	96,800 Added 14.39%	769,627 $242 Million

Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $77.4 Million - $87.1 Million	270,921 Added 67.41%	672,827 $194 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $31.5 Million - $35.2 Million	-115,213 Reduced 22.28%	401,906 $116 Million
Q2 2022 Aug 04, 2022	BUY	$234.96 - $292.55 $2.71 Million - $3.37 Million	11,535 Added 2.28%	517,119 $146 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $57.4 Million - $67.6 Million	259,205 Added 105.21%	505,584 $132 Million
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $7.46 Million - $9.42 Million	42,137 Added 20.63%	246,379 $54.1 Million
Q3 2021 Nov 08, 2021	SELL	$181.39 - $202.99 $16.6 Million - $18.6 Million	-91,765 Reduced 31.0%	204,242 $37 Million
Q2 2021 Aug 05, 2021	SELL	$187.49 - $221.1 $8.41 Million - $9.92 Million	-44,854 Reduced 13.16%	296,007 $59.7 Million
Q1 2021 May 05, 2021	SELL	$207.02 - $241.31 $12.6 Million - $14.7 Million	-60,917 Reduced 15.16%	340,861 $73.2 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $14.4 Million - $19.2 Million	-69,579 Reduced 14.76%	401,778 $95 Million
Q3 2020 Nov 09, 2020	BUY	$255.65 - $303.1 $12.5 Million - $14.9 Million	49,013 Added 11.6%	471,357 $128 Million
Q2 2020 Aug 04, 2020	BUY	$225.48 - $295.8 $8.85 Million - $11.6 Million	39,257 Added 10.25%	422,344 $123 Million
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $15.1 Million - $18.7 Million	-75,427 Reduced 16.45%	383,087 $91.2 Million
Q4 2019 Feb 11, 2020	SELL	$166.71 - $223.91 $10.3 Million - $13.8 Million	-61,714 Reduced 11.86%	458,514 $100 Million
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $9.14 Million - $10.3 Million	54,976 Added 11.82%	520,228 $88.1 Million
Q2 2019 Aug 02, 2019	BUY	$164.61 - $190.37 $15.1 Million - $17.5 Million	91,768 Added 24.57%	465,252 $85.3 Million
Q1 2019 Apr 26, 2019	BUY	$163.73 - $194.7 $3.21 Million - $3.82 Million	19,618 Added 5.54%	373,484 $68.7 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $6.83 Million - $8.64 Million	-44,937 Reduced 11.27%	353,866 $57.1 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $7.73 Million - $8.88 Million	46,095 Added 13.07%	398,803 $76.9 Million
Q2 2018 Aug 01, 2018	BUY	$145.72 - $169.96 $8.57 Million - $10 Million	58,841 Added 20.02%	352,708 $59.9 Million
Q1 2018 May 07, 2018	BUY	$151.6 - $177.13 $4.14 Million - $4.84 Million	27,333 Added 10.25%	293,867 $47.9 Million
Q4 2017 Feb 01, 2018	BUY	$137.28 - $155.55 $10.2 Million - $11.5 Million	74,089 Added 38.5%	266,534 $39.9 Million
Q3 2017 Nov 02, 2017	BUY	$148.13 - $162.24 $28.5 Million - $31.2 Million	192,445	192,445 $29.3 Million

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Vertex Pharmaceuticals Inc Transaction History